Purpose Hepatocellular carcinoma (HCC) has a poor prognosis, and alpha-fetoprotein
(AFP) is widely used to evaluate HCC. However, the proportion of AFP-negative individuals …

The aim of this study is to establish and validate an effective prognostic nomogram in
patients with AFP-negative hepatocellular carcinoma (HCC). The nomogram was based on …

Introduction As one of the most common malignant tumors in clinical practice, hepatocellular
carcinoma (HCC) is a major threat to human health, where alpha-fetoprotein (AFP) is widely …

Background: Alpha-fetoprotein-negative (< 20 ng/mL) hepatocellular carcinoma (AFP-
NHCC) cannot be easily diagnosed in clinical practice, which may affect early treatment and …

This study aimed to formulate reliable nomograms for predicting the outcomes of α-
fetoprotein (AFP)-negative hepatocellular carcinoma (HCC) patients after chemotherapy …

Purpose AFP appears to be negative in about 30% of overall hepatocellular carcinoma
(HCC). Our study aimed to develop a nomogram model to diagnose AFP-negative HCC …

Objective: To discuss the factors related to the prognosis in the alpha fetoprotein (AFP)
negative hepatocellular carcinoma (HCC) patients, and to construct the nomogram for …

Background Alpha-fetoprotein-negative hepatocellular carcinoma (AFP-NHCC)(< 8.78
ng/mL) have special clinicopathologic characteristics and prognosis. The aim of this study …

Background In AFP-negative hepatocellular carcinoma patients, markers for predicting
tumor progression or prognosis are limited. Therefore, our objective is to establish an …

Background Patients with alpha-fetoprotein (AFP)-positive hepatocellular carcinoma (HCC)
have aggressive biological behavior and poor prognosis. Therefore, survival time is one of …